The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(Z)-2-amino-5-(3-((4-chlorobenzyl)oxy)-4-methoxybenzylidene)thiazol-4(5H)-one ID: ALA5199977
PubChem CID: 156601217
Max Phase: Preclinical
Molecular Formula: C18H15ClN2O3S
Molecular Weight: 374.85
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(/C=C2\SC(N)=NC2=O)cc1OCc1ccc(Cl)cc1
Standard InChI: InChI=1S/C18H15ClN2O3S/c1-23-14-7-4-12(9-16-17(22)21-18(20)25-16)8-15(14)24-10-11-2-5-13(19)6-3-11/h2-9H,10H2,1H3,(H2,20,21,22)/b16-9-
Standard InChI Key: ZSEMSLCACOUIRO-SXGWCWSVSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
-1.4873 0.7982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7727 1.2105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0608 0.7986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0608 -0.0265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7709 -0.4383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4873 -0.0302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2019 -0.4428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9165 -0.0302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6700 -0.3657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2219 0.2472 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8096 0.9615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0027 0.7900 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-3.8834 -1.1622 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.2219 1.6757 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.6533 -0.4388 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.3675 -0.0265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0817 -0.4388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7960 -0.0266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5077 -0.4384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5077 -1.2633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7979 -1.6750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0817 -1.2670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2219 -1.6757 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.6533 1.2109 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.3675 0.7986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
6 7 1 0
7 8 2 0
9 8 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 8 1 0
9 13 2 0
11 14 1 0
4 15 1 0
15 16 1 0
16 17 1 0
18 17 2 0
19 18 1 0
20 19 2 0
21 20 1 0
22 21 2 0
17 22 1 0
20 23 1 0
3 24 1 0
24 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 374.85Molecular Weight (Monoisotopic): 374.0492AlogP: 3.86#Rotatable Bonds: 5Polar Surface Area: 73.91Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.86CX LogP: 3.48CX LogD: 3.48Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.80Np Likeness Score: -1.07
References 1. Zhang L, Tian J, Cheng H, Yang Y, Yang Y, Ye F, Xiao Z.. (2022) Identification of novel xanthine oxidase inhibitors via virtual screening with enhanced characterization of molybdopterin binding groups., 230 [PMID:35063733 ] [10.1016/j.ejmech.2022.114101 ]